The researchers studied the relationship between air quality and weekly fill rates for short-acting beta agonists in California, Washington and Oregon from July 5 to Sept. 30, using fine particulate matter pollution data as a measure of air quality.
Inhaling fine particulate matter pollution can be detrimental to a person’s health and can cause fatal complications for individuals infected with COVID-19.
More articles on pharmacy:
13 drugmakers contracted by Operation Warp Speed in 2020
US reportedly in talks with Pfizer to get more COVID-19 vaccine before June
GoodRx launches telehealth, free mail order pharmacy under subscription service
